Jos N. Hoes

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Jos N. Hoes, Johannes W. G. Jacobs, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2007 · 400 citations · Full text

Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

Jos N. Hoes, Marlies C. van der Goes, Daniël H. van Raalte et al. · Annals of the Rheumatic Diseases · 2011 · 112 citations · Full text

Metabolic effects of high‐dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction

Debby den Uyl, Daniël H. van Raalte, Michael T. Nurmohamed et al. · Arthritis & Rheumatism · 2011 · 68 citations

Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy

Suzanne Verstappen, Jos N. Hoes, E. J. ter Borg et al. · Annals of the Rheumatic Diseases · 2006 · 46 citations · Full text

Are Glucocorticoids DMARDs?

J. W. J. Bijlsma, Jos N. Hoes, Amalia A. van Everdingen et al. · Annals of the New York Academy of Sciences · 2006 · 34 citations

Early Disease, Immunology, Pharmacotherapy +22